Medinotec (MDNC) EBITDA Margin (2022 - 2026)

Medinotec (MDNC) posted EBITDA Margin of 6.82% for Q2 2026, up 147.05% on a QoQ basis from 14.5% in Q1 2026, and down 618.0% year-over-year from 1.32% in Q2 2025.

Medinotec (MDNC) EBITDA Margin (2022 - 2026) Analysis & Trends

Medinotec's EBITDA Margin history runs 5 years deep, the most recent figure standing at 6.82% for Q2 2026.

  • Quarterly EBITDA Margin fell 618.0% year-over-year to 6.82% in Q2 2026, while the trailing twelve-month figure through May 2026 was 9.74% (down 2217.0% YoY) and the FY2026 annual result came in at 11.25%, down 2377.0% from the prior year.
  • EBITDA Margin was 6.82% for Q2 2026 at Medinotec, up from 14.5% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 55.58% in Q1 2025 and bottomed at 127.02% in Q3 2022.
  • A 5-year average of 1.22% and a median of 11.91% in 2023 frame the typical range for EBITDA Margin.
  • Annual changes were most pronounced in 2023 — EBITDA Margin surged 14290 bps — and 2026, when it tumbled 7008 bps.
  • Medinotec's EBITDA Margin stood at 6.57% in 2022, then jumped by 96 bps to 12.88% in 2023, then soared by 60 bps to 20.56% in 2024, then advanced by 6 bps to 21.79% in 2025, then plunged by 69 bps to 6.82% in 2026.
  • Business Quant data shows MDNC's EBITDA Margin at 6.82% in Q2 2026, 14.5% in Q1 2026, and 21.79% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 183.74 Bn 176.45 Bn 6.27 Bn 12.05%
2 Stryker 128.89 Bn 126.01 Bn 3.81 Bn 15.55%
3 Medtronic 108.48 Bn 99.26 Bn 6.41 Bn 19.10%
4 Boston Scientific 68.51 Bn 67.05 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 48.32 Bn 44.65 Bn 1.29 Bn 28.97%
6 Dexcom 28.41 Bn 27.29 Bn 750.30 Mn 21.42%
7 GE HealthCare Technologies 28.23 Bn 25.95 Bn 1.98 Bn 10.04%
8 Smith & Nephew 26.90 Bn 26.32 Bn - -
9 Koninklijke Philips 24.47 Bn 21.35 Bn 2.07 Bn 6.17%
10 Medinotec 58.78 Mn 58.19 Mn 1.31 Mn 6.82%

Historic Data

Download Data
DateValue
May 31, 2026 6.82%
Feb 28, 2026 -14.50%
Nov 30, 2025 21.79%
Aug 31, 2025 16.33%
May 31, 2025 13.00%
Feb 28, 2025 55.58%
Nov 30, 2024 20.56%
Aug 31, 2024 24.15%
May 31, 2024 21.50%
Feb 29, 2024 10.93%
Nov 30, 2023 12.88%
Aug 31, 2023 15.89%
May 31, 2023 9.81%
Feb 28, 2023 -15.58%
Nov 30, 2022 6.57%
Aug 31, 2022 -127.02%
May 31, 2022 -24.43%
Feb 28, 2022 -32.31%